My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 271

    1.

    13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study.

    Handkiewicz-Junak D, Roskosz J, Hasse-Lazar K, Szpak-Ulczok S, Puch Z, Kukulska A, Olczyk T, Piela A, Paliczka-Cieslik E, Jarzab B.

    Thyroid Res. 2009 Aug 1;2(1):8.PMID: 19646277 [PubMed - in process]Free PMC ArticleFree textRelated citations

    2.

    Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.

    Jarzab B, Handkiewicz-Junak D, Roskosz J, Puch Z, Wygoda Z, Kukulska A, Jurecka-Lubieniecka B, Hasse-Lazar K, Turska M, Zajusz A.

    Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1077-86. Epub 2003 May 29.PMID: 12783219 [PubMed - indexed for MEDLINE]Related citations

    3.

    Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma.

    Courbon F, Zerdoud S, Bastie D, Archambaud F, Hoff M, Eche N, Berry I, Caron P.

    Thyroid. 2006 Oct;16(10):1025-31.PMID: 17042689 [PubMed - indexed for MEDLINE]Related citations

    4.

    Early sequential changes in serum thyroglobulin after radioiodine ablation for thyroid cancer: possible clinical implications for recombinant human thyrotropin-aided therapy.

    Taïeb D, Lussato D, Guedj E, Roux F, Mundler O.

    Thyroid. 2006 Feb;16(2):177-9.PMID: 16676403 [PubMed - indexed for MEDLINE]Related citations

    5.

    Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study.

    Simon D, Körber C, Krausch M, Segering J, Groth P, Görges R, Grünwald F, Müller-Gärtner HW, Schmutzler C, Köhrle J, Röher HD, Reiners C.

    Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):775-82. Epub 2002 Mar 13.PMID: 12029551 [PubMed - indexed for MEDLINE]Related citations

    6.

    Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.

    Giovanella L, Ceriani L, Suriano S, Ghelfo A, Maffioli M.

    Clin Endocrinol (Oxf). 2008 Oct;69(4):659-63. Epub 2008 Mar 18.PMID: 18363882 [PubMed - indexed for MEDLINE]Related citations

    7.

    Redifferentiation therapy with 13-cis retinoic acids in radioiodine-resistant thyroid cancer.

    Kim WG, Kim EY, Kim TY, Ryu JS, Hong SJ, Kim WB, Shong YK.

    Endocr J. 2009 Mar;56(1):105-12. Epub 2008 Oct 11.PMID: 18854619 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    8.

    Reproducibility of whole-body 131I scan and serum thyrotropin and stimulated thyroglobulin values in patients studied twice after injection of recombinant human thyrotropin.

    Niederkohr RD, McDougall IR.

    Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):363-7. Epub 2006 Sep 22.PMID: 17021814 [PubMed - indexed for MEDLINE]Related citations

    9.

    Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma.

    Pitoia F, Tamer EE, Schere DB, Passerieu M, Bruno OD, Niepomniszcze H.

    Medicina (B Aires). 2006;66(2):125-30.PMID: 16715760 [PubMed - indexed for MEDLINE]Related citations

    10.

    [Application of 13-cis-retinoic acid in patients with 131I scintigraphically-negative metastases of differentiated thyroid carcinoma]

    Adamczewski Z, Makarewicz J, Mikosiński S, Knapska-Kucharska M, Gunerska-Szadkowska A, Oszukowska L, Karwowska A, Lewiński A.

    Endokrynol Pol. 2006 Jul-Aug;57(4):403-6. Polish. PMID: 17006844 [PubMed - indexed for MEDLINE]Related citations

    11.

    Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake.

    Fernández CA, Puig-Domingo M, Lomeña F, Estorch M, Camacho Martí V, Bittini AL, Marazuela M, Santamaría J, Castro J, Martínez de Icaya P, Moraga I, Martín T, Megía A, Porta M, Mauricio D, Halperin I.

    J Endocrinol Invest. 2009 Mar;32(3):228-33.PMID: 19542739 [PubMed - indexed for MEDLINE]Related citations

    12.

    Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma.

    Coelho SM, Corbo R, Buescu A, Carvalho DP, Vaisman M.

    J Endocrinol Invest. 2004 Apr;27(4):334-9.PMID: 15233552 [PubMed - indexed for MEDLINE]Related citations

    13.

    [Use of 13-cis retinoic acid for treatment of advanced differentiated thyroid cancer]

    Handkiewicz-Junak D, Roskosz J, Turska M, Wygoda Z, Jarzab B.

    Wiad Lek. 2001;54 Suppl 1:301-6. Polish. PMID: 12182039 [PubMed - indexed for MEDLINE]Related citations

    14.

    Tumour re-differentiation effect of retinoic acid: a novel therapeutic approach for advanced thyroid cancer.

    Coelho SM, Vaisman M, Carvalho DP.

    Curr Pharm Des. 2005;11(19):2525-31. Review.PMID: 16026305 [PubMed - indexed for MEDLINE]Related citations

    15.

    Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.

    Hoftijzer H, Heemstra KA, Morreau H, Stokkel MP, Corssmit EP, Gelderblom H, Weijers K, Pereira AM, Huijberts M, Kapiteijn E, Romijn JA, Smit JW.

    Eur J Endocrinol. 2009 Dec;161(6):923-31. Epub 2009 Sep 22.PMID: 19773371 [PubMed - indexed for MEDLINE]Related citations

    16.

    The use of recombinant human thyrotropin (Thyrogen) in the diagnosis and treatment of thyroid cancer.

    Duntas LH, Tsakalakos N, Grab-Duntas B, Kalarritou M, Papadodima E.

    Hormones (Athens). 2003 Jul-Sep;2(3):169-74.PMID: 17003018 [PubMed]Free ArticleRelated citations

    17.

    Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer.

    Kebebew E, Lindsay S, Clark OH, Woeber KA, Hawkins R, Greenspan FS.

    Thyroid. 2009 Sep;19(9):953-6.PMID: 19678746 [PubMed - indexed for MEDLINE]Related citations

    18.

    Development of severe thyroid-associated ophthalmopathy in a patient with disseminated thyroid cancer treated with recombinant human thyrotropin/radioiodine and retinoic acid.

    Berg G, Andersson T, Sjödell L, Jansson S, Nyström E.

    Thyroid. 2005 Dec;15(12):1389-94.PMID: 16405414 [PubMed - indexed for MEDLINE]Related citations

    19.

    Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.

    Liu YY, Stokkel MP, Morreau HA, Pereira AM, Romijn JA, Smit JW.

    Clin Endocrinol (Oxf). 2008 Apr;68(4):605-9. Epub 2007 Nov 6.PMID: 17986279 [PubMed - indexed for MEDLINE]Related citations

    20.

    Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular cell origin.

    Zanotti-Fregonara P, Toubert ME, Taieb D, Ravasi L, Rubello D, Hindie E.

    Minerva Endocrinol. 2008 Jun;33(2):53-65. Epub 2008 Mar 11. Review.PMID: 18332849 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk